2m 2m 2m 2m 2m 2m 2m
Kaya Hldgs (KAYS)
OTC
$0.02-$0.009 (-37.50%)
Price as of Jun 03, 2026- $23.2MMarket Cap
- -54.82%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Kaya Hldgs (KAYS)
$0.02-$0.009 (-37.50%)
Annual
Quarterly
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 7,134 -96.37% | 196,294 -71.36% | 685,379 -22.98% | 889,899 -13.56% | |
Cost of Revenue | 7,500 -90.78% | 81,345 -63.86% | 225,107 -19.41% | 279,333 -10.09% | |
Gross Profit | -366 -100.32% | 114,949 -75.03% | 460,272 -24.62% | 610,566 -15.06% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 5,882 -50.34% | 11,845 -46.00% | 21,937 -81.57% | 119,039 -16.01% | |
Total Operating Expenses | 2.0M +48.72% | 1.4M -37.41% | 2.2M +6.44% | 2.0M -20.11% | |
Operating Profit | -2.0M +62.49% | -1.2M -27.29% | -1.7M +19.69% | -1.4M -22.08% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | -635,810 +5.48% | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 +100.00% | -635,810 +5.48% | |
Total Nonoperating Income and Expense | -38,083 -139.46% | 96,501 +105.01% | -1.9M -116.60% | 11.6M +1,825.20% | |
Income before Taxes | -2.1M -224.12% | 1.7M +145.63% | -3.6M -135.75% | 10.2M +182.75% | |
Income Taxes | N/A N/A | 23,327 -75.16% | 93,910 N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -2.1M -229.27% | 1.6M +145.01% | -3.6M -138.08% | 9.4M +176.39% | |
Net Income from Continuing Operations Applicable to Common | -2.1M -227.98% | 1.6M +145.01% | -3.6M -138.08% | 9.4M +176.39% | |
Basic EPS and Net Income | -0.07 N/A | N/A N/A | N/A N/A | N/A N/A | |
Diluted EPS and Net Income | -0.07 N/A | N/A N/A | N/A N/A | N/A N/A | |
Basic Weighted Average Shares | 28.4M N/A | N/A N/A | N/A N/A | N/A N/A | |
Diluted Weighted Average Shares | 257.7M N/A | N/A N/A | N/A N/A | N/A N/A | |
Balance Sheet | |||||
Cash and Cash Equivalents | 39,668 +36.28% | 29,108 +58.80% | 18,330 -96.76% | 565,979 +1,211.29% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 39,668 +36.28% | 29,108 +58.80% | 18,330 -96.76% | 565,979 +1,211.29% | |
Total Current Assets | 67,938 -29.93% | 96,955 +65.80% | 58,478 -90.74% | 631,430 +513.55% | |
Accumulated Depreciation | 372,390 +71.70% | 216,890 -39.48% | 358,396 -1.63% | 364,331 -33.45% | |
Property and Plant and Equipment and Net | 46,131 +85.45% | 24,875 -32.26% | 36,720 -93.61% | 574,733 -68.51% | |
Total Long-Term Assets | 148,431 +24.84% | 118,901 -84.85% | 784,763 -16.31% | 937,683 -57.30% | |
Total Assets | 216,369 +0.24% | 215,856 -74.40% | 843,241 -46.26% | 1.6M -31.74% | |
Income Taxes Payable | 902,166 +0.31% | 899,344 +2.66% | 876,017 +12.01% | 782,107 N/A | |
Total Short-Term Debt | 135,000 +8.60% | 124,312 +1,234.97% | 9,312 -72.86% | 34,312 -90.55% | |
Total Current Liabilities | 5.2M -30.35% | 7.4M -28.92% | 10.4M +28.78% | 8.1M -60.68% | |
Total Long-Term Debt | 8.7M +18.71% | 7.3M +1.84% | 7.2M -0.08% | 7.2M -46.43% | |
Total Long-Term Liabilities | 12.2M +42.35% | 8.6M +6.63% | 8.0M +1.80% | 7.9M +18.61% | |
Total Liabilities | 17.3M +8.63% | 16.0M -13.45% | 18.4M +15.46% | 16.0M -41.31% | |
Retained Earnings | -38.5M +5.71% | -36.5M -4.23% | -38.1M +10.37% | -34.5M -21.99% | |
Total Stockholders Equity | -15.0M -868.72% | 2.0M +112.52% | -15.6M +24.11% | -12.6M -49.51% | |
Total Shares Outstanding | 41.5M +87.01% | 22.2M 0.00% | 22.2M +50.60% | 14.7M +3.21% | |
Cash Flow | |||||
Cash from Operating Activities | -830,820 -20.56% | -1.0M +13.82% | -918,799 -11.95% | -1.0M +260.30% | |
Capital Expenditures | 27,138 N/A | N/A N/A | N/A N/A | 11,721 N/A | |
Cash from Investing Activities | 4,012 -99.51% | 812,859 +4,632.25% | 17,177 -98.65% | 1.3M +4,120.51% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 1.0M +309.84% | 245,000 -33.78% | 370,000 +25.00% | 296,000 +6.67% | |
Financials Ratio | |||||
Gross Margin | -5.13% -108.76% | 58.56% -12.80% | 67.16% -2.12% | 68.61% -1.74% | |
Operating Margin | -28,343.54% +4,370.89% | -633.96% +153.88% | -249.71% +55.41% | -160.67% -9.86% | |
Return on Assets | -962.86% -416.76% | 303.98% +202.51% | -296.52% -161.05% | 485.70% +197.82% | |
Return on Equity | 31.83% +235.10% | -23.56% -192.90% | 25.36% +150.64% | -50.08% -178.23% | |
Revenue Growth | -96.37% +35.04% | -71.36% +210.50% | -22.98% +69.44% | -13.56% -1,000.52% | |
Current Ratio | 0.01 +0.76% | 0.01 +133.93% | 0.006 -92.83% | 0.08 +1,462.00% | |
Cash Ratio | 0.008 +97.44% | 0.004 +116.67% | 0.002 -97.43% | 0.07 +3,233.33% | |
Debt-to-Equity Ratio | -0.59 -115.42% | 3.80 +926.40% | -0.46 -19.77% | -0.57 +3.78% | |
Debt-to-Assets Ratio | 40.74 +18.26% | 34.45 +304.09% | 8.52 +85.30% | 4.60 -23.23% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow